Page last updated: 2024-08-24

amprenavir and Exanthem

amprenavir has been researched along with Exanthem in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huynh, P; Kohli-Pamnani, A; Lobo, F	1
Brothers, C; Fetter, A; Millard, J; Pagano, G; Pedneault, L; Tymkewycz, P; Yeo, J	1
Lloyd, PP; Lou, Y; Piliero, PJ; Preston, SL; Sadler, BM; Stein, DS	1

Trials

2 trial(s) available for amprenavir and Exanthem

Article	Year
Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection. Clinical therapeutics, 2000, Volume: 22, Issue:12 Topics: Adolescent; Adult; Anti-HIV Agents; Carbamates; Child; Child, Preschool; Digestive System; Drug Therapy, Combination; Exanthema; Female; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Paresthesia; Sulfonamides	2000
Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers. AIDS (London, England), 2001, May-25, Volume: 15, Issue:8 Topics: Administration, Oral; Adult; Body Mass Index; Carbamates; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exanthema; Female; Furans; HIV Protease Inhibitors; HIV Seronegativity; Humans; Male; Middle Aged; Nausea; Ritonavir; Statistics, Nonparametric; Sulfonamides	2001

Article

Year

Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection.

Clinical therapeutics, 2000, Volume: 22, Issue:12

Topics: Adolescent; Adult; Anti-HIV Agents; Carbamates; Child; Child, Preschool; Digestive System; Drug Therapy, Combination; Exanthema; Female; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Paresthesia; Sulfonamides

2000

Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers.

AIDS (London, England), 2001, May-25, Volume: 15, Issue:8

Topics: Administration, Oral; Adult; Body Mass Index; Carbamates; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exanthema; Female; Furans; HIV Protease Inhibitors; HIV Seronegativity; Humans; Male; Middle Aged; Nausea; Ritonavir; Statistics, Nonparametric; Sulfonamides

2001

Other Studies

2 other study(ies) available for amprenavir and Exanthem

Article	Year
Amprenavir-induced maculopapular exanthem followed by desensitization in a patient with late-stage human immunodeficiency virus. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 96, Issue:4 Topics: Adult; Carbamates; Desensitization, Immunologic; Drug Hypersensitivity; Exanthema; Female; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Sulfonamides	2006
Amprenavir: a new HIV protease inhibitor. The Medical letter on drugs and therapeutics, 1999, Jul-16, Volume: 41, Issue:1057 Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Carbamates; Child; Clinical Trials as Topic; Cross Reactions; Diarrhea; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Exanthema; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Nausea; Stevens-Johnson Syndrome; Sulfonamides	1999

Article

Year

Amprenavir-induced maculopapular exanthem followed by desensitization in a patient with late-stage human immunodeficiency virus.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 96, Issue:4

Topics: Adult; Carbamates; Desensitization, Immunologic; Drug Hypersensitivity; Exanthema; Female; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Sulfonamides

2006

Amprenavir: a new HIV protease inhibitor.

The Medical letter on drugs and therapeutics, 1999, Jul-16, Volume: 41, Issue:1057

Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Carbamates; Child; Clinical Trials as Topic; Cross Reactions; Diarrhea; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Exanthema; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Nausea; Stevens-Johnson Syndrome; Sulfonamides

1999